Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10691522
United States Court of Appeals for the Ninth Circuit
Curtis v. Inslee
No. 10691522 · Decided October 6, 2025
No. 10691522·Ninth Circuit · 2025·
FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
October 6, 2025
Citation
No. 10691522
Disposition
See opinion text.
Full Opinion
FOR PUBLICATION
UNITED STATES COURT OF APPEALS
FOR THE NINTH CIRCUIT
AILA CURTIS; CIERA AGEE; No. 24-1869
ALISON ARCHER; SHANNON
D.C. No.
LEE ADAMS; BECKY
3:23-cv-05741-
BARCENAS; HANNAH
RJB
BERNHARDT; KATHY
BORDEAUX; CHRISTINE AMBER
BRUCE; SUSAN BUCHANAN; OPINION
KIRSTEN CLARKE; DIANE
CLEMANS; JEFF COFFEY;
DEREK COINER; SHEILA CRAIG;
RAE LYNN CROCKER; LISA
DALUZ; CHRISTINA DAWSON;
MARGARITA DEMCHENKO;
MONICA DICKINSON; HAYLEY
DIXON; JASON DONG; SHANTA
GERVICKAS; EDUARD
GONCHARUK; AMY HASEROT;
BETHENY HAYDEN; RHONDA
HOLMES; MIKAYLA
HOLSINGER; SUMIKO KUBA;
NADEZHDA LITVINENKO;
LILIYA LOPATIN; MISTY
LYONS; SHEILA LYONS; IRINA
MAKSIMENKO; LYUBOV
MELNYCHUK; ASHLEY
MENDOZA; MONICA MILLER;
CHERYL MITCHELL; DAMARIS
MOCAN; KATHRYN MORGAN;
2 CURTIS V. INSLEE
NICK MORZHOV; DWAIN NASH;
LYSANDER NERIDA; KATHRYN
ORTEGA; YVONNE QUASHIE;
LESLIE QUINTANA; EMMA
RANSON; SHANNON
RINGNALDA; MALLORY
SCHLANG; MELISSA
SMITHDEAL; LORI SOUDERS;
BROOKE TANNER; TRACIE
THOMAS; DENA THORP;
JENNIFER TORRES; LYUBOV
TSHUPRIN; OLGA TSYTSYNA;
ROXANA VOLYNETS; HANNAH
WAGER; VERA YADLOVSKIY;
ALLA KUTSAR ZABOLOTSKA;
DINA ZABOLOTSKA; NELYA
ZABOLOTSKA; KRISTINE
ZAMUDIO; DANIEL BRICKERT;
AMY JAMES; BRITNEY BROWN;
NELLI ANTONOV; DAVID
BENNETT; AMBER TAYLOR;
TAMARA KOPP; WHITNEY
KONRADY; JOSEY KOLBO;
LINDSEY LAMB; KATERINA
EROKHINA; IGOR SHAPOVAL;
WHITNEY ONOFREY; AMY
TALLBUT; VIOLETTA ROBERTS;
LINDA VEATCH; ANGELA RIPP;
KRISTIN ELLISON; STACI GRAY,
Plaintiffs - Appellants,
v.
CURTIS V. INSLEE 3
JAY ROBERT INSLEE;
PEACEHEALTH, INC.; LIZ
DUNNE; DOUG KOEKKOEK,
Defendants - Appellees.
Appeal from the United States District Court
for the Western District of Washington
Robert J. Bryan, District Judge, Presiding
Argued and Submitted July 9, 2025
Seattle, Washington
Filed October 6, 2025
Before: M. Margaret McKeown, Richard A. Paez, and
Gabriel P. Sanchez, Circuit Judges.
Opinion by Judge McKeown
SUMMARY *
Employment/COVID-19
The panel affirmed the district court’s dismissal for
failure to state a claim of an action brought by former at-will
employees of a nonprofit health care system (Employees)
*
This summary constitutes no part of the opinion of the court. It has
been prepared by court staff for the convenience of the reader.
4 CURTIS V. INSLEE
alleging various statutory, constitutional, and state law
claims arising from then-Governor Jay Inslee’s August 2021
proclamation requiring healthcare workers in Washington to
be vaccinated against COVID-19.
The panel first held that none of the Employees’
statutory and non-constitutional claims alleged specific and
definite rights enforceable under 42 U.S.C. § 1983. The
panel therefore rejected Employees’ claims based on 21
U.S.C. § 360bbb-3, 10 U.S.C. § 980, 42 U.S.C. § 247d-6,
Article VII of the International Covenant on Civil and
Political Rights, 45 C.F.R. Part 46, the Belmont Report, the
Federal Wide Assurance Agreement, the COVID-19
Vaccination Program Provider Agreement, and Emergency
Use Authorizations.
Addressing the Employees’ constitutional claims, the
panel held that neither the Spending Clause nor the
Supremacy Clause provided Employees with a federal right
enforceable under § 1983. Employees’ claims under the
Fourteenth Amendment Due Process Clause failed. The
substantive due process claim alleging the right to refuse
unwanted investigational drugs was foreclosed by
Jacobson v. Massachusetts, 197 U.S. 11 (1905), and Health
Freedom Def. Fund, Inc. v. Carvalho, 148 F.4th 1020 (9th
Cir. 2025) (en banc). The procedural due process claim
failed because, among other things, the Employees’ at-will
employment was not a constitutionally protected property
interest. Employees’ Equal Protection Clause claim,
asserting a claim of discrimination against a non-suspect
class, failed because the mandate here survived rational-
basis review.
Because amendment of the federal claims would be
futile, the panel held that the district court did not abuse its
CURTIS V. INSLEE 5
discretion in denying leave to amend the complaint. The
panel affirmed the dismissal of the state law claims alleging
breach of contract, employment tort, outrage, and invasion
of privacy against the Governor. As for the state-law claims
against PeaceHealth, the panel upheld the district court’s
discretion to decline to exercise supplemental jurisdiction.
COUNSEL
David J. Schexnaydre (argued), Schexnaydre Law Firm
LLC, Mandeville, Louisiana; Charice L. Holtsclaw,
Bellingham, Washington; for Plaintiffs-Appellants.
Ian D. Rogers (argued), Kai A. Smith, Zachary J. Pekelis,
and Meha Goyal, Pacifica Law Group LLP, Seattle,
Washington; Whitney A. Brown (argued), Stoel Rives LLP,
Anchorage, Alaska; Vanessa S. Power and Jenna M. Poligo,
Stoel Rives LLP, Seattle, Washington; for Defendants-
Appellees.
6 CURTIS V. INSLEE
OPINION
McKEOWN, Circuit Judge:
We have considered a spate of appeals related to
vaccination orders spawned by COVID-19. This case arises
from then-Governor Jay Inslee’s August 2021 proclamation
requiring healthcare workers in Washington to be vaccinated
against COVID-19. Aila Curtis and more than 80 other
former at-will employees of the nonprofit health care system
PeaceHealth (“Employees”) were terminated after they
refused to comply with PeaceHealth’s COVID-19
vaccination policy. Employees’ claims against PeaceHealth
and Governor Inslee range from statutory and constitutional
claims under 42 U.S.C. § 1983 to state-law contract and tort
claims. The district court dismissed all claims with
prejudice. Although Employees throw the kitchen sink at the
Proclamation, none of their wide-ranging sources of
purported rights supports their federal claims. As for the
state-law claims, the district court correctly dismissed with
prejudice the claims against the Governor and left the merits
of the claims against PeaceHealth for state courts to
adjudicate. The district court acted within its discretion in
denying leave to amend.
Because we affirm on the basis of Employees’ failure to
state a claim, we do not decide the questions of state action
and qualified immunity addressed by the district court. We
also note that our analysis holds even if the drug in question
was deemed “investigational,” as Employees assert; any
claimed error by the district court in its view of the facts
pertaining to this issue is harmless. We affirm.
CURTIS V. INSLEE 7
Background
On August 20, 2021, then-Governor of Washington State
Jay Inslee (“the Governor”) issued Proclamation 21-14 (“the
Proclamation”), which, absent an exemption, required
healthcare workers to be vaccinated against COVID-19
before October 18, 2021. In accord with this directive, on
August 30, PeaceHealth adopted a vaccination mandate for
its employees, with a deadline of October 15. Because
Employees refused to be vaccinated, PeaceHealth
terminated their employment.
Employees sued PeaceHealth and its executives
(collectively, “PeaceHealth”), as well as the Governor,
seeking damages. Employees allege that, leading up to the
vaccination deadline, the sole available vaccine to satisfy the
vaccination mandate was an “investigational drug,”
authorized only for emergency use. 1 Despite the fact that the
Pfizer vaccine authorized for emergency use and the Pfizer
vaccine fully approved by the Food and Drug Administration
undisputedly had the same “medical formulation,”
Employees claim that their rights were violated when they
were penalized for refusing a vaccine that was only EUA-
1
The Food and Drug Administration (“FDA”) issued an Emergency Use
Authorization (“EUA”) for Pfizer’s COVID-19 vaccine in January 2021.
Authorizations of Emergency Use of Two Biological Products During
the COVID–19 Pandemic; Availability, 86 Fed. Reg. 5200 (January 19,
2021). By August 2021, Pfizer’s EUA-authorized COVID-19 vaccines
had been manufactured and made available for many months.
As the district court noted, on August 23, 2021, the FDA approved
Pfizer’s COVID-19 vaccine, marketed as COMIRNATY. See We The
Patriots USA, Inc. v. Hochul, 17 F.4th 266, 283 (2d Cir. 2021) (“[T]he
FDA gave full approval to the Pfizer-BioNTech vaccine for individuals
16 years of age and older.”). We take as true Employees’ factual
assertion that Pfizer’s COVID-19 vaccines manufactured under FDA
approval were not available before the relevant vaccination deadlines.
8 CURTIS V. INSLEE
authorized and not yet FDA-approved. Employees also
claim they were not adequately informed of their option to
refuse administration of the vaccine. Employees contend that
these rights are enforceable through a variety of sources—
ranging from multiple federal statutes to the Fourteenth
Amendment to the terms of the agreements under which
COVID-19 vaccines (or “investigational drugs”) were
administered.
The district court first dismissed all of the claims against
the Governor, then dismissed the federal claims against
PeaceHealth, and finally denied Employees’ motions for
leave to amend and reconsideration and declined to exercise
supplemental jurisdiction over their state-law claims against
PeaceHealth.
Analysis
I. Statutory and Other Non-Constitutional Claims
Section 1983 authorizes private parties to sue for
violations of their constitutional rights and certain federal
statutory rights. 42 U.S.C. § 1983. Because a statutory right
enforceable under Section 1983 is not created “as a matter of
course,” Health & Hosp. Corp. of Marion Cnty. v. Talevski,
599 U.S. 166, 183 (2023), Employees must “prove that a
statute secures an enforceable right, privilege, or immunity,
and does not just provide a benefit or protect an interest.”
Medina v. Planned Parenthood S. Atl., 145 S. Ct. 2219, 2229
(2025). 2 Provisions that place a “merely precatory
2
“Plaintiffs suing under § 1983 do not have the burden of showing an
intent to create a private remedy because § 1983 generally supplies a
remedy for the vindication of rights secured by federal statutes. . . . Once
a plaintiff demonstrates that a statute confers an individual right, the right
is presumptively enforceable by § 1983.” Gonzaga Univ. v. Doe, 536
U.S. 273, 280, 284 (2002).
CURTIS V. INSLEE 9
obligation” on the government do not create enforceable
rights. Ball v. Rodgers, 492 F.3d 1094, 1103 (9th Cir. 2007).
Although the existence of an “unambiguously
conferred,” “sufficiently specific and definite” statutory
right establishes a presumption of enforceability under
Section 1983, Gonzaga Univ. v. Doe, 536 U.S. 273, 280, 283
(2002) (citation omitted), that presumption can be overcome.
A Section 1983 claim will not be available where there is
“incompatibility between enforcement under § 1983 and the
enforcement scheme that Congress has enacted.” Talevski,
599 U.S. at 187.
Employees’ non-constitutional claims under Section
1983—styled as “subjected to investigational drug use,”
“unconstitutional conditions doctrine,” equal protection, due
process, and “spending clause doctrine”—are based on an
eclectic collection of statutes, an international treaty, a
regulation, two agreements, a report, and constitutional
doctrines and provisions. After considering each in turn, our
conclusion is unequivocal: None of these claims alleges a
specific and definite right enforceable by Employees under
Section 1983.
A. 21 U.S.C. § 360bbb-3 – “EUA Statute”
The statutory provision referred to by Employees as “the
EUA Statute” or 21 U.S.C. § 360bbb-3, a section of the
Food, Drug, and Cosmetic Act (“FDCA”), empowers the
FDA to authorize the use of a drug in certain circumstances.
Under this statute, the Secretary of Health and Human
Services is obliged to design “[a]ppropriate conditions . . . to
ensure that individuals to whom the product is administered
are informed . . . of the option to accept or refuse
administration of the product.” 21 U.S.C. § 360bbb-
3(e)(1)(A)(ii). Employees argue that Defendants did not
10 CURTIS V. INSLEE
adequately inform them of their option to refuse the COVID-
19 vaccine, thereby violating the statute.
Even assuming this language applies to Defendants and
their conduct, Congress has limited the enforcement of the
FDCA to public actions. Id. § 337(a) (requiring that
enforcement be brought “by and in the name of the United
States”). Contrary to Employees’ wishes, we cannot
“judicially creat[e] an implied private right of action.”
Instead, our role is to interpret Congress’s intent in creating
a private right. “In the absence of clear evidence of
congressional intent, we may not usurp the legislative power
by unilaterally creating a cause of action.” In re Digimarc
Corp. Derivative Litig., 549 F.3d 1223, 1230–31 (9th Cir.
2008). By providing only for public enforcement, Congress
has made its intent to “shut the door to private enforcement”
evident. Gonzaga Univ., 536 U.S. at 284 n.4. Employees
have not provided evidence of any contrary Congressional
intent or even a colorable interpretation of the statute that
would enable their suit. We conclude that Section 360bbb-3
does not create a private right that is enforceable under
Section 1983.
B. 10 U.S.C. § 980 – “Funds Appropriated for
Human Subjects”
This statute, 10 U.S.C. § 980, provides that “[f]unds
appropriated to the Department of Defense may not be used
for research involving a human being as an experimental
subject.” Spending-power statutes, like this one, are
“especially unlikely” to confer an enforceable right. Medina,
145 S. Ct. at 2230. This statute contains no language
“phrased in . . . explicit rights-creating terms.” Gonzaga, 536
U.S. at 284. Nor does it “manifest[] an ‘unambiguous’ intent
CURTIS V. INSLEE 11
to confer individual rights” and so is not enforceable under
Section 1983. Id. at 280 (citation omitted).
C. 42 U.S.C. § 247d-6 – “Public Readiness and
Emergency Preparedness Act”
The Public Readiness and Emergency Preparedness Act
(“PREP Act”), 42 U.S.C. § 247d-6, requires the Secretary of
Health and Human Services to “ensure that . . . potential
participants [in the administration or use of a covered
countermeasure] are educated with respect to . . . the
voluntary nature of the program.” Id. § 247d-6e(c).
Employees extrapolate from this statute a “right” to be so
educated and thus hang their hat on this statute as a basis for
their Section 1983 claims. The PREP Act, however, lacks
the requisite “rights-creating language” and “individual[]
focus” to create rights enforceable under Section 1983.
Gonzaga, 536 U.S. at 290. Further, the statute, at most,
imposes an educational obligation on a federal agency, not
Defendants. Plaintiffs’ PREP Act claim therefore fails.
D. Article VII of the International Covenant on Civil
and Political Rights
The International Covenant on Civil and Political Rights
(“ICCPR”) is a treaty that protects certain human rights.
Some treaties—those that are either self-executing or
legislatively implemented—can confer enforceable rights
under Section 1983. See, e.g., Olympic Airways v. Husain,
540 U.S. 644, 646 (2004) (upholding the imposition of
liability under Article 17 of the Warsaw Convention);
Missouri v. Holland, 252 U.S. 416, 431 (1920) (discussing
the Migratory Bird Treaty Act of 1918 as legislative
implementation that “g[a]ve effect” to a 1916 treaty between
the United States and Great Britain); see also Medellín v.
Texas, 552 U.S. 491, 568–69 (2008) (appendix listing
12 CURTIS V. INSLEE
“Supreme Court decisions considering a treaty provision to
be self-executing”).
However, the ICCPR was ratified by the United States
“on the express understanding that it was not self-executing
and so did not itself create obligations enforceable in the
federal courts.” Sosa v. Alvarez-Machain, 542 U.S. 692, 735
(2004). Because the ICCPR is not self-executing, and
Congress has not acted to enable private lawsuits for
violations of rights enshrined in that treaty, it is not
“susceptible to judicial enforcement.” Serra v. Lappin, 600
F.3d 1191, 1196 (9th Cir. 2010) (citation omitted). Article
VII of the ICCPR thus cannot serve as the basis for a Section
1983 action. See Medellín, 552 U.S. at 505 (concluding that
absent self-executing status or implementing statutes, such
treaties’ commitments are “not domestic law”); Frolova v.
Union of Soviet Socialist Republics, 761 F.2d 370, 373 (7th
Cir. 1985) (holding that a treaty “do[es] not provide the basis
for a private lawsuit” if it is neither self-executing nor
implemented by legislation).
E. 45 C.F.R. Part 46 – “Human Subjects in
Research”
Employees contend that Defendants, in administering
“investigational drugs,” were “bound to comply” with 45
C.F.R. Part 46, which concerns the protection of human
subjects in research. 45 C.F.R. §§ 46.101, et seq. But even if
these regulations applied to the conduct at issue here, a
regulation “may not create a right that Congress has not.”
Alexander v. Sandoval, 532 U.S. 275, 291 (2001); see also
Save Our Valley v. Sound Transit, 335 F.3d 932, 936 (9th
Cir. 2003). Employees do not argue that any authorizing
CURTIS V. INSLEE 13
statutes create any right enforceable under Section 1983. 3
The regulation, standing alone, cannot support Employees’
claims.
F. The Belmont Report
The Belmont Report outlines “basic ethical principles”
and their application in the conduct of research on human
subjects. National Commission for the Protection of Human
Subjects of Biomedical and Behavioral Research, The
Belmont Report (April 18, 1979),
https://www.hhs.gov/ohrp/regulations-and-policy/belmont-
report/read-the-belmont-report/index.html, accessed May 9,
2025. The Belmont Report is neither a statute nor a
regulation. It does not carry the force of law. It contains no
hint of a legal right or remedy enforceable in U.S. courts.
Employees’ claims based on the Belmont Report also fail.
G. The Federal Wide Assurance Agreement
Like the Belmont Report, the Federal Wide Assurance
agreement (“FWA”) is far afield from any potential rights-
creating source. The FWA is an agreement between the U.S.
Department of Health and Human Services and any
institution involved in federally funded research, under
which the institution commits to complying with
requirements in 45 C.F.R. Part 46 and the Belmont Report.
Employees argue that the FWA created a duty to obtain
“legally effective informed consent” from them and “to
ensure that at no time is an individual under ‘coercion,’
3
If a “statute itself confers a specific right upon the plaintiff, and a valid
regulation merely further defines or fleshes out the content of that right,
then the statute—in conjunction with the regulation—may create a
federal right as further defined by the regulation.” Save our Valley, 335
F.3d at 941 (quoting Harris v. James, 127 F.3d 993, 1009 (11th Cir.
1997)).
14 CURTIS V. INSLEE
‘undue influence,’ ‘unjustifiable pressures’ or a sanction to
participate” in the administration of an investigational drug.
Notably, the language regarding “coercion” and similar
phrases comes from the Belmont Report, not the FWA. Even
if the FWA created such a duty, and such a duty applied to
Defendants, the FWA does not create rights enforceable
under Section 1983. See Save Our Valley, 335 F.3d at 941–
42. Employees, who bear the burden of proving the existence
of a right enforceable under Section 1983, have failed to
point to any “explicit rights-creating terms” in the FWA
itself. Gonzaga, 536 U.S. at 284. Their sole citation is to a
federal government website that explains the general nature
of the FWA. This basis for Employees’ Section 1983 claim
too fails.
H. The COVID-19 Vaccination Program Provider
Agreement
The COVID-19 Vaccination Program Provider
Agreement (“Provider Agreement”) is “a form contract
between the [Center for Disease Control] and medical
providers that plan to administer COVID-19 vaccines.” As
relevant, medical providers are to “provide a[] . . . fact sheet
. . . to each vaccine recipient, the adult caregiver
accompanying the recipient, or other legal representative.”
The contract also incorporates “all applicable requirements
as set forth by the U.S. Food and Drug Administration.”
Employees contend that the Provider Agreement, by
incorporating all federal requirements, required the medical
providers to “accept[] the Appellants’ freely chosen option”
to refuse the administration of the drug at issue. Once more,
such an agreement cannot create enforceable rights under
Section 1983. Id.
CURTIS V. INSLEE 15
Nor do Employees meet the requirements for bringing
suit as direct third-party beneficiaries to a government
contract. Employees bear the burden of demonstrating that
they individually can enforce any right created by the
contract and seek damages. See Indep. Living Ctr. of S. Cal.,
Inc. v. Kent, 909 F.3d 272, 280 (9th Cir. 2018). Where, as
here, third-party beneficiaries seek consequential damages
for failure to perform under a government contract, that
burden has two requirements: 1) that “the terms of the
promise provide for such liability,” Restatement (Second) of
Contracts § 313(2)(a); and 2) that the plaintiffs “fall within
a class clearly intended by the parties to benefit from the
contract.” Orff v. United States, 358 F.3d 1137, 1145 (9th
Cir. 2004) (citation omitted).
Employees meet neither requirement. The Provider
Agreement contemplates fines and imprisonment as
penalties but does not address private enforcement. Cf. Cent.
Bank of Denver, N.A. v. First Interstate Bank of Denver,
N.A., 511 U.S. 164, 190 (1994) (“We have been quite
reluctant to infer a private right of action from a criminal
prohibition alone.”). Nothing in the Provider Agreement
even hints at the option for a damages claim. As for the
second requirement, if there are any direct beneficiaries to
the Provider Agreement, those would be “vaccine
recipient[s].” As the district court pointed out, Employees
are not vaccine recipients but rather vaccine refusers. Once
again, Employees have not demonstrated that they have a
right to sue under this type of agreement.
I. Emergency Use Authorizations
Emergency use authorizations (“EUAs”) are letters from
the Chief Scientist of the FDA to drug manufacturers. These
letters contain conditions of authorization, including the
16 CURTIS V. INSLEE
requirement of distribution of “authorized labeling” to
“vaccination providers, recipients, and caregivers.” Yet
again, these letters do not confer rights enforceable under
Section 1983. Nor are the Employees direct beneficiaries of
these letters such that they could possibly sue in contract—
they are neither the senders nor the recipients of these letters,
and they have not alleged that they are “vaccination
providers, recipients, [or] caregivers.”
II. Constitutional Provisions
A. Spending Clause
Employees style one of their Section 1983 claims under
the “Spending Clause Doctrine,” presumably referring 10
U.S.C. § 980, governing the use of Department of Defense
funds. While statutes enacted pursuant to the Spending
Clause “can create § 1983-enforceable rights,” the operative
question is whether they “actually do so.” Talevski, 599 U.S.
at 180. That question is answered by our discussion of the
statutes above. The invocation of the Spending Clause does
not change the analysis.
B. Supremacy Clause
When discussing the PREP Act and the “EUA Statute,”
Employees invoke “preemption” in their complaint and
briefs. To the extent Employees rely on the Supremacy
Clause as a basis for their Section 1983 claims, this argument
fails. The Supremacy Clause itself “is not a source of any
federal rights” enforceable under Section 1983. Golden State
Transit, 493 U.S. at 107 (citation omitted). The “availability
of the § 1983 remedy turns on whether the statute[s]” that
Employees argue preempt state action create enforceable
rights. We already concluded they do not.
CURTIS V. INSLEE 17
C. Fourteenth Amendment Due Process
a. Substantive Due Process
Employees’ efforts to situate their claims under the
Fourteenth Amendment Due Process Clause also fail.
Employees claim Defendants violated their substantive due
process right “to refuse unwanted investigational drugs.”
The “substantive protection of the Due Process Clause”
extends to “[o]nly those aspects of liberty that we as a society
traditionally have protected as fundamental.” Mullins v.
Oregon, 57 F.3d 789, 793 (9th Cir. 1995). Because
fundamental rights are highly circumscribed, courts are
“reluctant to expand the concept of substantive due process.”
Regino v. Staley, 133 F.4th 951, 962 (9th Cir. 2025) (citation
omitted). Employees must therefore articulate a “careful
description” of a fundamental right. Stormans, Inc. v.
Wiesman, 794 F.3d 1064, 1085 (9th Cir. 2015) (quoting
Washington v. Glucksberg, 521 U.S. 702, 728 (1997)). If a
fundamental right is implicated, we apply strict scrutiny.
Witt v. Dep’t of Air Force, 527 F.3d 806, 817 (9th Cir.
2006)). If a fundamental liberty interest is not implicated, we
apply rational basis review, which is “highly deferential to
the government, allowing any conceivable rational basis to
suffice.” Health Freedom Def. Fund, Inc. v. Carvalho, 148
F.4th 1020, 1029 (9th Cir. 2025) (en banc) (quotation
omitted). 4
Employees’ clearest articulation of the right they assert
is the “right to refuse an investigational drug without penalty
4
We recently rejected a similar challenge to a COVID-19 vaccine
mandate. In Carvalho, we held that the “constitutionality of a vaccine
mandate . . . turns on what reasonable legislative and executive
decisionmakers could have rationally concluded about whether a vaccine
protects the public’s health and safety.” Id. at 1031.
18 CURTIS V. INSLEE
or pressure.” It is undisputed that the “investigational drug”
is a COVID-19 vaccine and that the Governor and
PeaceHealth believed compulsory vaccination for healthcare
workers would protect public health. In fact, the vaccine
even has the same “medical formulation” as a vaccine that
was FDA-approved before the issuance of PeaceHealth’s
vaccination policy and thus prior to Employees’ refusals. On
this record, for the purposes of this analysis, there is no
material distinction between the refusal of a vaccine and
Employees’ refusal of administration of an investigational
drug that is clinically identical to a vaccine.
Under longstanding Supreme Court precedent, the right
to refuse a vaccine is not inviolate. Penalties for refusing
vaccination are plainly permissible. The Supreme Court in
Jacobson v. Massachusetts upheld a vaccination-refusal
penalty of “commit[ment] until [a] fine was paid” and
indicated the permissibility of “manifold restraints,”
including quarantine. 197 U.S. 11, 21, 26 (1905); see also
Zucht v. King, 260 U.S. 174, 175 (1922) (upholding the
exclusion of a student from school for refusing vaccination).
When we consider “substantive due process challenges to
COVID-19 vaccine mandates,” our analysis is controlled by
Jacobson. Carvalho, 148 F.4th at 1029.
Specifically, under Jacobson, penalties justified by
public health concerns are legitimate. The court in Jacobson
was crystal clear that, because “a community has the right to
protect itself against an epidemic of disease which threatens
the safety of its members,” a vaccine mandate that has a “real
or substantial relation to the protection of public health” is
not “in palpable conflict with the Constitution.” 197 U.S. at
27, 31. Thus, the Court in Jacobson “essentially applied
rational basis review” to the smallpox vaccine mandate and
found it survived such deferential review. Carvalho, 148
CURTIS V. INSLEE 19
F.4th at 1030. In Carvalho, applying Jacobson, we reached
the same conclusion with respect to a vaccination policy
imposed for closely analogous reasons, at nearly the same
time, as the vaccine mandates at issue here. In that case,
applying rational basis review, we upheld the vaccine policy
because it was “more than reasonable for the [state actors] to
conclude that COVID-19 vaccines would protect the health
and safety of [the relevant populations].” Id.
Jacobson and Carvalho foreclose Employees’
substantive due process claim regarding the purported “right
to refuse an investigational drug without penalty or
pressure.” The penalties imposed on Employees were amply
justified by public health concerns, as explained elsewhere
in this opinion. Employees have failed to plausibly allege
that the state action in this case was an exercise of “arbitrary
power” rather than merely “that broad discretion required for
the protection of the public health.” Zucht, 260 U.S. at 177.
We therefore conclude that Employees have not stated a
substantive due process claim based on the right to refuse the
COVID-19 vaccine at issue.
Employees’ substantive due process claim regarding the
PREP Act’s grant of immunity also fails. Even if there exists
some constitutional limit on the Congressional power to
grant immunity, Employees have pointed to no authority
suggesting that the PREP Act exceeds that limit. Employees
cannot allege a deprivation of their ability to bring suit, as
they have had an opportunity to be heard in this action. And,
of course, Employees are not entitled to damages in the
absence of a meritorious claim. As for any right to
“educat[ion] with respect to the voluntary nature of the
program,” Employees have not shown a deprivation of that
right. Materials provided to recipients and caregivers made
clear that “it is [their] choice to receive or not receive any of
20 CURTIS V. INSLEE
these vaccines,” and consent forms acknowledged their right
to refuse.
b. Procedural Due Process
Employees’ procedural due process claim fares no better.
Employees’ at-will employment with PeaceHealth is not a
constitutionally protected property interest under the
Fourteenth Amendment. Portman v. Cnty. of Santa Clara,
995 F.2d 898, 904 (9th Cir. 1993) (holding that at-will
employees “ha[ve] no property interest in the[ir] job[s]”). In
the absence of a deprivation of a protected interest,
Employees cannot make out a procedural due process claim.
See Reed v. Goertz, 598 U.S. 230, 236 (2023).
Employees also allege a deprivation of a protected
liberty interest in the refusal of unwanted administration of
a drug and a protected property interest in the use of their
medical licenses (asserted in the Second Amended
Complaint). Assuming without deciding that Employees
have adequately alleged a deprivation, they have not
plausibly alleged that they have not received all the process
that was due.
Unlike their prior pleadings, Employees’ Second
Amended Complaint claims that the Governor gave
Employees no “date, time, place, or procedure to defend
their right to refuse injection . . . before depriving them of
their liberty and property.” 5 However, the Proclamation
provided notice of the vaccination requirements and of the
consequence of termination for failure to comply. The
Proclamation also required that healthcare workers be given
opportunities to be heard for the purpose of religious and
5
The Second Amended Complaint does not make any assertions on this
point as to PeaceHealth.
CURTIS V. INSLEE 21
medical exemptions and that assessments for qualification
for such exemptions be “individualized.” Employees do not
contend that they sought and were deprived of an exemption
without due process.
Indeed, it is difficult to characterize Employees’
complaint in the usual framework of a procedural due
process challenge. A typical challenge concerns a plaintiff
who, subjected to a permissible standard by the state, seeks
to show that “there is no [non-discriminatory] basis for their
finding that he fails to meet these standards.” Schware v. Bd.
of Bar Exam. of State of N.M., 353 U.S. 232, 239 (1957). The
ordinary purpose of the due process inquiry is to fulfill “the
public interest in correct eligibility determinations,” and thus
the ordinary question is one of factual “eligibility.”
Goldberg v. Kelly, 397 U.S. 254, 266 (1970).
Here, by contrast, Employees seek to challenge the
standards themselves: either the breadth of the mandate or
the narrowness of the exemptions. But the legitimacy of a
standard—as opposed to the process by which the state
determines whether the Employee meets that standard—is
not a question to be answered by procedural due process.
The Supreme Court long ago held that “legislation is not
open to the charge of depriving one of his rights without due
process of law, if it be general in its operation upon the
subjects to which it relates.” Dent v. West Virginia, 129 U.S.
114, 124 (1889). The Governor was under no obligation to
hold a town hall for Employees to make known their various
complaints regarding the Proclamation. The process the state
created for granting exemptions “fulfilled the purpose of the
requisite pretermination hearing”: to “provide a meaningful
hedge against erroneous action.” Clements v. Airport Auth.
of Washoe Cnty., 69 F.3d 321, 332 & n.13 (9th Cir. 1995)
22 CURTIS V. INSLEE
(quoting Cleveland Bd. of Educ. v. Loudermill, 470 U.S.
532, 543 n.8 (1985)).
Employees’ procedural due process challenge—better
construed as a bid to alter the state’s policies, rather than its
procedures—fails.
D. Equal Protection
Employees assert a claim of discrimination against a
non-suspect class, cf. New York City Transit Auth. v. Beazer,
440 U.S. 568, 592–93 (1979), namely, a class of “healthcare
workers . . . choosing the option to refuse.” However, the
Proclamation “appl[ied] evenhandedly” to all healthcare
workers in Washington State, except for its religious and
medical exemptions. Beazer, 440 U.S. at 587. The presence
of the exemptions splits Employees’ articulated class in two:
those workers who refused and had exemptions (and so were
not penalized), and those workers who refused and did not
have exemptions (and so were penalized). The “exclusionary
line” of vaccination status challenged by Employees simply
does not reflect the reality of the policy, which allows
exemptions for medical and religious reasons. Id. at 592. We
are hard-pressed to conclude that they have “confronted [us]
with the question whether the rule reflects an impermissible
bias against a special class.” Id. at 588.
Even if the vaccine mandates classify such that the Equal
Protection Clause applies, our “only inquiry” is whether
Employees’ treatment is “rationally related to the State’s
objective.” Harrah Indep. Sch. Dist. v. Martin, 440 U.S. 194,
199 (1979) (quoting Mass. Bd. of Ret. v. Murgia, 427 U.S.
307 315 (1976)); see also Carvalho, 148 F.4th at 1033. We
conclude that the state action here easily survives rational-
basis review.
CURTIS V. INSLEE 23
Rational-basis review affords government actions a
“strong presumption of validity.” Aleman v. Glickman, 217
F.3d 1191, 1200 (9th Cir. 2000) (citation omitted). It is
satisfied where the state decisionmaker “could rationally
have decided” that its action would further a legitimate state
interest. Minnesota v. Clover Leaf Creamery Co., 449 U.S.
456, 466 (1981) (emphasis omitted). “Under rational basis
review, the state actor has no obligation to produce evidence
to sustain the rationality of a . . . classification; rather, the
burden is on the one attacking the . . . arrangement to
negative every conceivable basis which might support it.”
Johnson v. Rancho Santiago Cmty. Coll. Dist., 623 F.3d
1011, 1031 (9th Cir. 2010) (internal quotations and citation
omitted).
Early in the pandemic, we reiterated that “[s]temming
the spread of COVID-19” is not merely a legitimate state
interest; it is “unquestionably a compelling” one.
Slidewaters LLC v. Wash. State Dep’t of Lab. & Indus., 4
F.4th 747, 758 (9th Cir. 2021) (quoting Roman Cath.
Diocese of Brooklyn v. Cuomo, 592 U.S. 14, 18 (2020)). In
Biden v. Missouri, the Supreme Court recently articulated
the public-health rationale underlying vaccine mandates for
healthcare workers:
COVID–19 is a highly contagious,
dangerous, and—especially for Medicare and
Medicaid patients—deadly disease. The
Secretary of Health and Human Services
determined that a COVID-19 vaccine
mandate will substantially reduce the
likelihood that healthcare workers will
contract the virus and transmit it to their
patients. . . . He accordingly concluded that a
24 CURTIS V. INSLEE
vaccine mandate is “necessary to promote
and protect patient health and safety” in the
face of the ongoing pandemic.
595 U.S. 87, 93 (2022).
That decision plainly demonstrates that a state
decisionmaker “could rationally have decided” that a
vaccine mandate for healthcare workers would further the
legitimate state interest of stemming the spread of COVID-
19. Thus, the mandate here survives rational-basis review.
Clover Leaf Creamery, 449 U.S. at 466.
Employees provide no factually supported argument to
undermine this conclusion. Employees only note that “[a]n
investigational drug does not have a legal indication to treat,
cure, or prevent any known disease or virus.” But the
absence of a legal indication does not negate the obvious
inference that the available COVID-19 vaccine would be
rationally related to the protection of public health. See
Rancho Santiago Cmty. Coll. Dist., 623 F.3d at 1031. For
example, the Proclamation recognized that based on
“clinical trials involving tens of thousands of participants”
and “the [FDA’s] rigorous scientific standards” for
emergency use authorization, the available COVID-19
vaccines are “safe and effective.” See also Carvalho, 148
F.4th at 1033 (concluding that an August 2021 COVID-19
vaccination mandate for public school teachers easily
survived rational basis review). And, in this case, Employees
even concede that the vaccine available to them had the same
medical formulation and effectiveness as an FDA-approved
COVID-19 vaccine. If there were any state action
constituting differential treatment of Employees as a class,
that action had a rational basis. Employees’ equal protection
challenge fails.
CURTIS V. INSLEE 25
III. Denial of Leave to Amend
We review for abuse of discretion the district court’s
denial of leave to amend. Herring Networks, Inc. v.
Maddow, 8 F.4th 1148, 1155 (9th Cir. 2021). Employees
appeal that denial only with respect to their federal claims.
Denial of leave to amend was proper because amendment of
those claims would be futile. Cervantes v. Countrywide
Home Loans, Inc., 656 F.3d 1034, 1041 (9th Cir. 2011). No
amendment to Employees’ existing claims could change the
absence of a source of law conferring on them a right
enforceable under Section 1983. Employees’ one novel
claim in the Second Amended Complaint, an invocation of
21 U.S.C. § 355(a), another provision of the FDCA, fails for
the same reasons as did their claim under 21 U.S.C.
§ 360bbb-3. Nor do Employees’ proposed amendments alter
our analysis with respect to the constitutional claims. The
Second Amended Complaint reiterates that the EUA-
authorized and FDA-approved vaccines “can be used
interchangeably to provide the vaccination series.” In light
of that continued allegation, an inference in favor of
Employees’ inconsistent new assertion that the EUA-
authorized vaccine does not “stop infection or transmission”
of COVID-19 would be unreasonable. On review of a
motion to dismiss, we need draw only those reasonable
inferences in the Employees’ favor, not all potential
inferences. See Ashcroft v. Iqbal, 556 U.S. 662, 678–79
(2009).
Employees’ attempt to distinguish Jacobson by
comparing fatality rates from smallpox to fatality rates from
COVID-19 does not change the equal protection analysis
under rational-basis review, particularly given that
stemming the spread of COVID-19 is a “compelling”
interest. Roman Cath. Diocese of Brooklyn, 592 U.S. at 18.
26 CURTIS V. INSLEE
Nor does this new assertion disturb our conclusion that
Jacobson forecloses Employees’ substantive due process
claim. See Carvalho, 148 F.4th at 1029–31. Further,
Employees’ attempt to distinguish Jacobson on this ground
fails under Carvalho, which rejected attempts to distinguish
Jacobson on similar grounds. Id. at 1033. Employees’
proposed amendment regarding procedural due process
“fail[s] to cure the pleading deficiencies.” Cervantes, 656
F.3d at 1041.
Because amendment would be futile, the district court
did not abuse its discretion in denying leave to amend the
complaint.
IV. Dismissal of State Law Claims
Employees brought four claims under Washington state
law: “breach of contract,” “employment tort,” “outrage,” and
“invasion of privacy.” We review de novo the district court’s
dismissal of the state-law claims as to the Governor. Laws.
for Fair Reciprocal Admission v. United States, 141 F.4th
1056, 1063 (9th Cir. 2025). We review for abuse of
discretion the district court’s decision not to exercise
supplemental jurisdiction over the state-law claims as to
PeaceHealth and thus to dismiss them without prejudice.
Bryant v. Adventist Health Sys./W., 289 F.3d 1162, 1165 (9th
Cir. 2002).
The breach-of-contract claim was properly dismissed
because the Governor was not a signatory to the Provider
Agreement, the contract at issue, and therefore had no duty
that could have been breached. The employment-tort claim
was dismissed because Employees did not allege that the
Governor was acting as their employer. The invasion-of-
privacy claim was dismissed because Employees’
allegations did not relate to any actions taken by the
CURTIS V. INSLEE 27
Governor. Employees do not specifically dispute any of
these determinations on appeal.
As to the outrage claim against the Governor, the district
court concluded that “[t]he properly credited allegations in
the Amended Complaint are insufficient from which to
conclude that the Proclamation was ‘beyond all possible
bounds of decency’ considering the circumstances at the
time,” and therefore could not meet an element of outrage
under Washington state law. On de novo review, even
assuming that the drugs were “investigational,” we are
unpersuaded that Employees have alleged facts sufficient to
“state a claim to relief that is plausible on its face.” Iqbal,
556 U.S. at 678. As the Supreme Court noted with respect to
a similar federal vaccine mandate, “[v]accination
requirements are a common feature of the provision of
healthcare in America: Healthcare workers around the
country are ordinarily required to be vaccinated for diseases
such as hepatitis B, influenza, and measles, mumps, and
rubella.” Biden, 595 U.S. at 95. At the time of the
Proclamation, the drug in question was already authorized
for emergency use to prevent COVID-19. The record shows
that the CDC had concluded months earlier that the drug had
a 92% efficacy and that taking the EUA-authorized drug was
associated with “reduced risk for . . . severe outcomes” of
infection with COVID-19. Within three days of the
Proclamation’s issuance, a vaccine with an identical medical
formulation was fully approved by the FDA. Given the
backdrop of common vaccination requirements for
healthcare workers, the Proclamation does not remotely
constitute conduct “utterly intolerable in a civilized
community.” Kloepfel v. Bokor, 66 P.3d 630, 632 (Wash.
2003) (emphasis omitted). We affirm the district court’s
dismissal of the outrage claim as to the Governor.
28 CURTIS V. INSLEE
As for the state-law claims against PeaceHealth, we
uphold the district court’s discretion to decline to exercise
supplemental jurisdiction. The district court concluded that
it had “dismissed all claims over which it ha[d] original
jurisdiction,” and that the remaining state-law claims “raise[]
novel or complex issues of state law,” two of the important
factors that trigger a court’s discretion to decline
supplemental jurisdiction. Acri v. Varian Assocs., Inc., 114
F.3d 999, 1000 n.2 (9th Cir. 1997) (en banc) (citing 28
U.S.C. § 1367(c)). In exercising that discretion, the court
appropriately noted that the decision served the value of
comity and possibly also the values of economy,
convenience, and fairness. The district court did not pass
judgment on whether the Employees had failed to state a
claim under state law or failed to assert rights protected
under state law. The court left those issues to the state courts
and was within its discretion in doing so.
AFFIRMED.
Plain English Summary
FOR PUBLICATION UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT AILA CURTIS; CIERA AGEE; No.
Key Points
01FOR PUBLICATION UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT AILA CURTIS; CIERA AGEE; No.
02LEE ADAMS; BECKY 3:23-cv-05741- BARCENAS; HANNAH RJB BERNHARDT; KATHY BORDEAUX; CHRISTINE AMBER BRUCE; SUSAN BUCHANAN; OPINION KIRSTEN CLARKE; DIANE CLEMANS; JEFF COFFEY; DEREK COINER; SHEILA CRAIG; RAE LYNN CROCKER; LISA DALUZ; CHRISTINA D
03INSLEE NICK MORZHOV; DWAIN NASH; LYSANDER NERIDA; KATHRYN ORTEGA; YVONNE QUASHIE; LESLIE QUINTANA; EMMA RANSON; SHANNON RINGNALDA; MALLORY SCHLANG; MELISSA SMITHDEAL; LORI SOUDERS; BROOKE TANNER; TRACIE THOMAS; DENA THORP; JENNIFER TORRES;
04INSLEE 3 JAY ROBERT INSLEE; PEACEHEALTH, INC.; LIZ DUNNE; DOUG KOEKKOEK, Defendants - Appellees.
Frequently Asked Questions
FOR PUBLICATION UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT AILA CURTIS; CIERA AGEE; No.
FlawCheck shows no negative treatment for Curtis v. Inslee in the current circuit citation data.
This case was decided on October 6, 2025.
Use the citation No. 10691522 and verify it against the official reporter before filing.